{"id":182,"date":"2023-03-03T16:07:43","date_gmt":"2023-03-03T21:07:43","guid":{"rendered":"https:\/\/sites.bu.edu\/griffiths-lab\/?post_type=profile&#038;p=182"},"modified":"2023-03-08T10:29:50","modified_gmt":"2023-03-08T15:29:50","slug":"sravya-nakka","status":"publish","type":"profile","link":"https:\/\/sites.bu.edu\/griffiths-lab\/profile\/sravya-nakka\/","title":{"rendered":"Sravya Nakka"},"content":{"rendered":"<p><span>Postdoctoral Associate (2023-present). Infection biologist by training with a Ph.D. in Biomedical Sciences from Orebro University, Sweden. Currently involved in studies focused on high containment level emerging pathogens. Prior experience in phase I\/II\/III human vaccine clinical trials (Ebola, Shigella\/ETEC), preclinical vaccine studies (COVID, HSV-2, HIV-1) and in vitro studies focused on immunomodulatory effects during host-pathogen interactions (<em>S. aureus, P. gingivalis and S. enterica<\/em>).<\/span><\/p>\n","protected":false},"author":22007,"template":"","_links":{"self":[{"href":"https:\/\/sites.bu.edu\/griffiths-lab\/wp-json\/wp\/v2\/profile\/182"}],"collection":[{"href":"https:\/\/sites.bu.edu\/griffiths-lab\/wp-json\/wp\/v2\/profile"}],"about":[{"href":"https:\/\/sites.bu.edu\/griffiths-lab\/wp-json\/wp\/v2\/types\/profile"}],"author":[{"embeddable":true,"href":"https:\/\/sites.bu.edu\/griffiths-lab\/wp-json\/wp\/v2\/users\/22007"}],"version-history":[{"count":5,"href":"https:\/\/sites.bu.edu\/griffiths-lab\/wp-json\/wp\/v2\/profile\/182\/revisions"}],"predecessor-version":[{"id":228,"href":"https:\/\/sites.bu.edu\/griffiths-lab\/wp-json\/wp\/v2\/profile\/182\/revisions\/228"}],"wp:attachment":[{"href":"https:\/\/sites.bu.edu\/griffiths-lab\/wp-json\/wp\/v2\/media?parent=182"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}